Professional Documents
Culture Documents
A R T I C L E I N F O
A B S T R A C T
Article history:
Received 30 March 2015
Received in revised form 19 June 2015
Accepted 20 June 2015
Available online 30 June 2015
Deep eutectic solvents (DES) can be formed by bioactive compounds or pharmaceutical ingredients. A
therapeutic DES (THEDES) based on ibuprofen, a non-steroidal anti-inammatory drug (NSAID), and
menthol was synthesized and its thermal behavior was analyzed by differential scanning calorimetry
(DSC). A controlled drug delivery system was developed by impregnating a starch:poly-e-caprolactone
polymeric blend (SPCL 30:70) with the menthol:ibuprofen THEDES in different ratios (10 and 20 wt%),
after supercritical uid sintering at 20 MPa and 50 C. The morphological characterization of SPCL
matrices impregnated with THEDES was performed by scanning electron microscopy (SEM) and microcomputed tomography (micro-CT). Drug release studies were carried out in a phosphate buffered saline.
The results obtained provide important clues for the development of carriers for the sustainable delivery
of bioactive compounds.
2015 Elsevier B.V. All rights reserved.
Keywords:
Therapeutic deep eutectic solvents
Supercritical carbon dioxide
Drug delivery systems
Biodegradable polymers
Ibuprofen
1. Introduction
Deep eutectic solvents (DES) have been presented as alternative
solvents for a variety of applications, similarly to the developments
observed with ionic liquids (ILs) in the early 90s (Abbott et al.,
2004; Paiva et al., 2014; Pena-Pereira and Namiesnik, 2014). DES
present, however, two major advantages that overcome the limited
applicability of ILs. DES, and particularly natural deep eutectic
solvents (NADES), are produced from naturally occurring molecules and have therefore inherent low toxicity (Dai et al., 2013).
Additionally they are formed by combining two or more
compounds that are solid at room temperature, which upon
mixing at a particular composition become liquid.
The development of therapeutic deep eutectic solvents
(THEDES) is a eld of research that has not been extensively
explored. Stott and co-workers reported that ibuprofen formed
eutectic mixtures with different terpenes that were shown to
74
75
76
Table 1
Experimental data obtained from DSC analysis for menthol, ibuprofen and 3:1
menthol:ibuprofen THEDES (taken at mid-point, in the rst DSC run).
Sample
Tg ( C)
Tc ( C)
Tm ( C)
Menthol
Ibuprofen
3:1 menthol:ibuprofen
41
50.1
16
29, 35
77
77
Fig. 6. (A) Scanning electron microscopy images; (B) micro-computed tomography cross-sections of SPCL (B1), SPCL + ibuprofen (B2); SPCL + 10% THEDES (B3), and SPCL + 20%
THEDES (B4).
SPCL
SPCL + ibuprofen
SPCL + 10% THEDES
SPCL + 20% THEDES
Porosity (%)
Interconnectivity (%)
13
23
17
44
3
8
7
28
Fig. 7. Pore size distribution of the matrices prepared using supercritical uid
sintering.
78
Mt
Ktn
Minf
Fig. 8. Percentage of ibuprofen released from SPCL + ibuprofen, SPCL + 10% THEDES
and SPCL + 20% THEDES matrices.
and the diffusion of the active compounds from the bulk of the
matrix to the solution (Siepmann and Peppas, 2001). The fact that
THEDES is in the liquid form, together with the higher porosity of
the matrices, may help to understand this behavior. Nonetheless,
matrices loaded with ibuprofen and 10% THEDES have similar
morphological characteristics and SPCL + 10% THEDES has a faster
release rate. On the other hand, for the same time period studied
the sample SPCL + 20% THEDES released 80% of the ibuprofen
loaded. The release of the sample with 20% THEDES did not reach
100% during the time frame evaluated, which may be due to
diffusion constrictions of the active compound from the core of the
matrix to the media.
After 21 days, the pH of the samples was measured and it was
observed that the pH decreased to 7.02 in the case of SPCL (used as
control), to 6.56 in the case of SPCL + ibuprofen (mixture of the two
powders also used as control), to 6.70 for SPCL + 10% THEDES, and
to 6.46 for SPCL + 20% THEDES.
The mathematical modeling of the release of THEDES from the
polymeric matrix can further elucidate the mechanisms governing
the release. Several empirical and semi-empirical mathematical
models have been derived from Ficks law of diffusion (Costa et al.,
2001; Siepmann and Gopferich, 2001; Siepmann and Peppas,
2001). The Korsmeyer-Peppas model is a semi-empirical model
which can be used to relate the amount of drug released with time
when the release deviates from the purely Fickian diffusion (Costa
et al., 2001; Siepmann and Peppas, 2011).
This model relies, however, on several assumptions that cannot
be disregarded. This model assumes that the diffusion is one
dimensional, the swelling is negligible, the diffusivity is constant
and the release experiments were carried out under sink
conditions, i.e., the equilibrium was not altered throughout the
duration of the experiment (Siepmann and Peppas, 2011). At these
conditions, can be applied to the systems studied:
Table 3
Release exponent and kinetic constant of the release systems prepared.
Sample
R2
SPCL + ibuprofen
SPCL + 10% THEDES
SPCL + 20% THEDES
0.41
0.46
0.46
0.099
0.147
0.137
0.9955
0.9835
0.9960
(2)
References
Abbott, A.P., Boothby, D., Capper, G., Davies, D.L., Rasheed, R.K., 2004. Deep eutectic
solvents formed between choline chloride and carboxylic acids: versatile
alternatives to ionic liquids. J. Am. Chem. Soc. 126, 91429147.
Alves, A., Duarte, A.R.C., Mano, J.F., Sousa, R.A., Reis, R.L., 2012. PDLLA enriched with
ulvan particles as a novel 3D porous scaffold targeted for bone engineering. J.
Supercrit. Fluids 65, 3238.
Balmayor, E.R., Feichtinger, G.A., Azevedo, H.S., van Griensven, M., Reis, R.L., 2009.
Starch-poly-N-caprolactone Microparticles Reduce the Needed Amount of
BMP-2. Clin. Orthop. Relat. Res. 467, 31383148.
Bhamidipati, M., Sridharan, B., Scurto, A.M., Detamore, M.S., 2013. Subcritical CO2
sintering of microspheres of different polymeric materials to fabricate scaffolds
for tissue engineering. Mater. Sci. Eng. C 33, 48924899.
Bica, K., Rodriguez, H., Gurau, G., Cojocaru, O.A., Riisager, A., Fehrmann, R., Rogers, R.
D., 2012. Pharmaceutically active ionic liquids with solids handling, enhanced
thermal stability, and fast release. Chem. Commun. 48, 54225424.
Bras, A.R., Noronha, J.P., Antunes, A.M.M., Cardoso, M.M., Schonhals, A., Affouard, F.,
Dionisio, M., Correia, N.T., 2008. Molecular motions in amorphous ibuprofen as
studied by broadband dielectric spectroscopy. J. Phys. Chem. B 112, 11087
11099.
Carriazo, D., Serrano, M.C., Gutierrez, M.C., Ferrer, M.L., del Monte, F., 2012. Deepeutectic solvents playing multiple roles in the synthesis of polymers and related
materials. Chem. Soc. Rev. 41, 49965014.
Corvis, Y., Negrier, P., Massip, S., Leger, J.M., Espeau, P., 2012. Insights into the crystal
structure, polymorphism and thermal behavior of menthol optical isomers and
racemates. Crystengcomm 14, 70557064.
Costa, P., Manuel, J., Lobo, S., 2001. Modeling and comparison of dissolution proles.
Eur. J. Pharm. Sci. 13, 123133.
Craveiro, R., Martins, M., Santos, G.B., Correia, N., Dionisio, M., Barreiros, S., Duarte,
A.R.C., Reis, R.L., Paiva, A., 2014. Starch-based polymer-IL composites formed by
compression moulding and supercritical uid foaming for self-supported
conductive materials. RSC Adv. 4, 1716117170.
Dai, Y.T., van Spronsen, J., Witkamp, G.J., Verpoorte, R., Choi, Y.H., 2013. Natural deep
eutectic solvents as new potential media for green technology. Anal. Chim. Acta
766, 6168.
Duarte, A.R.C., Mano, J.F., Reis, R.L., 2009a. Dexamethasone-loaded scaffolds
prepared by supercritical-assisted phase inversion. Acta Biomater. 5, 2054
2062.
Duarte, A.R.C., Mano, J.F., Reis, R.L., 2009b. Supercritical uids in biomedical and
tissue engineering applications: a review. Int. Mater. Rev. 54, 214222.
Duarte, A.R.C., Santo, V.E., Alves, A., Siiva, S.S., Moreira-Silva, J., Silva, T.H., Marques,
A.P., Sousa, R.A., Gomes, M.E., Mano, J.F., Reis, R.L., 2013. Unleashing the potential
of supercritical uids for polymer processing in tissue engineering and
regenerative medicine. J. Supercrit. Fluid 79, 177185.
Dudognon, E., Danede, F., Descamps, M., Correia, N.T., 2008. Evidence for a new
crystalline phase of racemic ibuprofen. Pharm. Res.-Dord 25, 28532858.
Knez, Z., Markocic, E., Novak, Z., Hrncic, M.K., 2011. Processing polymeric
biomaterials using Supercritical CO2. Chem. Ing. Tech. 83, 13711380.
Lu, D.R., Xiao, C.M., Xu, S.J., 2009. Starch-based completely biodegradable polymer
materials. Express Polym. Lett. 3, 366375.
79
Malafaya, P.B., Silva, G.A., Reis, R.L., 2007. Natural-origin polymers as carriers and
scaffolds for biomolecules and cell delivery in tissue engineering applications.
Adv. Drug Deliv. Rev. 59, 207233.
Mano, J.F., Silva, G.A., Azevedo, H.S., Malafaya, P.B., Sousa, R.A., Silva, S.S., Boesel, L.F.,
Oliveira, J.M., Santos, T.C., Marques, A.P., Neves, N.M., Reis, R.L., 2007. Natural
origin biodegradable systems in tissue engineering and regenerative medicine:
present status and some moving trends. J. Royal Soc. Inter. 4, 9991030.
Marques, A.P., Reis, R.L., Hunt, J.A., 2002. The biocompatibility of novel starch-based
polymers and composites: in vitro studies. Biomaterials 23, 14711478.
Morrison, H.G., Sun, C.C., Neervannan, S., 2009. Characterization of thermal
behavior of deep eutectic solvents and their potential as drug solubilization
vehicles. Int. J. Pharm. 378, 136139.
Paiva, A., Craveiro, R., Aroso, I., Martins, M., Reis, R.L., Duarte, A.R.C., 2014. Natural
deep eutectic solventssolvents for the 21st century. Acs. Sustain. Chem. Eng. 2,
10631071.
Pena-Pereira, F., Namiesnik, J., 2014. Ionic liquids and deep eutectic mixtures:
sustainable solvents for extraction processes. Chemsuschem 7, 17841800.
Reis, A.V., Guilherme, M.R., Moia, T.A., Mattoso, L.H.C., Muniz, E.C., Tambourgi, E.B.,
2008. Synthesis and characterization of a starch-modied hydrogel as potential
carrier for drug delivery system. J. Polym. Sci. Pol. Chem. 46, 25672574.
Russ, C., Konig, B., 2012. Low melting mixtures in organic synthesis - an alternative
to ionic liquids? Green Chem. 14, 29692982.
Salerno, A., Pascual, C.D., 2015. Bio-based polymers, supercritical uids and tissue
engineering. Process Biochem. 50, 826838.
Siepmann, J., Gopferich, A., 2001. Mathematical modeling of bioerodible, polymeric
drug delivery systems. Adv. Drug Deliv. Rev. 48, 229247.
Siepmann, J., Peppas, N.A., 2001. Modeling of drug release from delivery systems
based on hydroxypropyl methylcellulose (HPMC). Adv. Drug. Deliv. Rev. 48, 139
157.
Siepmann, J., Peppas, N.A., 2011. Higuchi equation: derivation, applications, use and
misuse. Int. J. Pharm. 418, 612.
Silva, G.A., Costa, F.J., Neves, N.M., Reis, R.L., 2004. Microparticulate release systems
based on natural origin materials. Adv. Exp. Med. Biol. 553, 283300.
Singh, M., Sandhu, B., Scurto, A., Berkland, C., Detamore, M.S., 2010. Microspherebased scaffolds for cartilage tissue engineering: using subcritical CO2 as a
sintering agent. Acta Biomater. 6, 137143.
Stott, P.W., Williams, A.C., Barry, B.W., 1998. Transdermal delivery from eutectic
systems: enhanced permeation of a model drug, ibuprofen. J. Controlled Release
50, 297308.
Tuntarawongsa, S., Phaechamud, T., 2012a. Menthol, borneol, camphor and WS-3
eutectic mixture. Biomater. Appl. 506, 355358.
Tuntarawongsa, S., Phaechamud, T., 2012b. Polymeric eutectic system. Adv. Mater.
Res. Switz 528, 180183.
Wang, H., Gurau, G., Shamshina, J., Cojocaru, O.A., Janikowski, J., MacFarlane, D.R.,
Davis, J.H., Rogers, R.D., 2014. Simultaneous membrane transport of two active
pharmaceutical ingredients by charge assisted hydrogen bond complex
formation. Chem. Sci. 5, 34493456.
Williams, H.D., Trevaskis, N.L., Charman, S.A., Shanker, R.M., Charman, W.N., Pouton,
C.W., Porter, C.J.H., 2013. Strategies to address low drug solubility in discovery
and development. Pharmacol. Rev. 65, 315499.
Zhang, A.J., Zhang, Q.K., Bai, H., Li, L., Li, J., 2014. Polymeric nanoporous materials
fabricated with supercritical CO2 and CO2-expanded liquids. Chem. Soc. Rev. 43,
69386953.